Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers - PubMed (original) (raw)

Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers

S Meri et al. Immunology. 1990 Sep.

Abstract

Human cells are relatively resistant to lysis by the homologous complement system. Here we describe the mechanism of action of a recently discovered and widely distributed 18,000-20,000 molecular weight (MW) membrane glycoprotein (CD59), which appears to act as a major protective element against complement-mediated lysis (hence called protectin). When incorporated into heterologous erythrocyte membranes, protectin efficiently prevented cell lysis by human serum. Neutralization with antibody of the naturally occurring protectin on human erythrocytes or on nucleated K562 cells increased their susceptibility to lysis by homologous complement. During complement activation, protectin became incorporated into the membrane attack complex (MAC). By interacting with newly exposed regions in the C5b-8 complex and in aggregating C9 it limited the number of C9 molecules associating with the C5b-8 complex to a C8:C9 ratio of 1:1.5 instead of a normal average of 1:3.5. The results demonstrate directly that protectin is a powerful inhibitor of complement cytolysis and acts by inhibiting the C5b-8 catalysed insertion of C9 into the lipid bilayer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1989 Nov 15;264(32):19228-35 - PubMed
    1. Nature. 1988 Sep 29;335(6189):448-51 - PubMed
    1. Mol Immunol. 1989 Feb;26(2):153-61 - PubMed
    1. J Biol Chem. 1988 Jan 5;263(1):549-60 - PubMed
    1. J Immunol Methods. 1984 Oct 12;73(1):203-20 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources